Docoh
Loading...

BFRA Biofrontera

Filed: 25 Feb 21, 11:12am

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO

RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of February 2021

 

Commission File Number: 001-38396

 

BIOFRONTERA AG

(Registrant’s name / Translation of registrant’s name into English)

 

Hemmelrather Weg 201, D-51377 Leverkusen Germany

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F [X] Form:40-F [  ]

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): N/A

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): N/A

 

 

 

 

 

 

EXHIBITS

 

Exhibit Number Description
99.1 

Biofrontera AG: Biofrontera AG announces entry of capital increase into the commercial register

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 BIOFRONTERA AG
   
 By:/s/ Hermann Lübbert
 Name:Hermann Lübbert
 Title:Chief Executive Officer
   
 By:/s/ Thomas Schaffer
 Name:Thomas Schaffer
 Title:Chief Financial Officer

 

Date: February 25, 2021